Brief: Gentian Diagnostics Q3 Sales Up At NOK 32.1 Mln
Oct 26 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* SALES OF MNOK 32.1 IN 3Q23, UP 39% VERSUS 3Q22
* EBITDA OF NOK 1.2 MILLION IN 3Q23 AND NOK 4.3 MILLION YTD
2023,
COMPARED TO EBITDA OF NOK -6.1 MILLION IN 3Q22 AND NOK -11.5
MILLION YTD 2022
Source text for Eikon: ID:nObiTMWT3a
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gentian Diagnostics ASA
See all newsBrief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company